Nyxoah S.A. (NASDAQ: NYXH) Stock Competitors & Peer Comparison
See NYXH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NYXH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NYXH | $1.55 | +0.65% | 155.1M | -0.62 | -$2.52 | N/A |
| ALC | $66.30 | -2.15% | 32.3B | 20.85 | $3.18 | +0.54% |
| STE | $209.90 | -0.18% | 20.5B | 20.14 | $10.42 | +1.23% |
| QDEL | $10.77 | +1.32% | 734.4M | 8.04 | $1.34 | N/A |
| MLAB | $125.29 | -1.46% | 701.1M | 12.64 | $9.91 | +0.50% |
| BWAY | $13.46 | +0.00% | 527.9M | 34.19 | $0.39 | N/A |
| MASS | $9.92 | -0.50% | 407M | -16.53 | -$0.60 | N/A |
| SI | $17.89 | -0.33% | 371.5M | -10.36 | -$1.73 | N/A |
| MOBI | $10.71 | -0.56% | 356.1M | -0.57 | -$18.78 | N/A |
| ANIK | $20.84 | -0.33% | 278.9M | 42.53 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
NYXH vs ALC Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, ALC has a market cap of 32.3B. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while ALC trades at $66.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas ALC's P/E ratio is 20.85. In terms of profitability, NYXH's ROE is -1.80%, compared to ALC's ROE of +0.03%. Regarding short-term risk, NYXH is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for NYXH.Check ALC's competition here
STERIS plc (NYSE: STE)
NYXH vs STE Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while STE trades at $209.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas STE's P/E ratio is 20.14. In terms of profitability, NYXH's ROE is -1.80%, compared to STE's ROE of +0.11%. Regarding short-term risk, NYXH is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for NYXH.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
NYXH vs QDEL Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, QDEL has a market cap of 734.4M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while QDEL trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas QDEL's P/E ratio is 8.04. In terms of profitability, NYXH's ROE is -1.80%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, NYXH is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
NYXH vs MLAB Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, MLAB has a market cap of 701.1M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while MLAB trades at $125.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas MLAB's P/E ratio is 12.64. In terms of profitability, NYXH's ROE is -1.80%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, NYXH is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
NYXH vs BWAY Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, BWAY has a market cap of 527.9M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while BWAY trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas BWAY's P/E ratio is 34.19. In terms of profitability, NYXH's ROE is -1.80%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, NYXH is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for NYXH.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
NYXH vs MASS Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, MASS has a market cap of 407M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while MASS trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas MASS's P/E ratio is -16.53. In terms of profitability, NYXH's ROE is -1.80%, compared to MASS's ROE of -0.25%. Regarding short-term risk, NYXH is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
NYXH vs SI Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, SI has a market cap of 371.5M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while SI trades at $17.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas SI's P/E ratio is -10.36. In terms of profitability, NYXH's ROE is -1.80%, compared to SI's ROE of -0.26%. Regarding short-term risk, NYXH is similarly volatile compared to SI. This indicates similar risk in terms of short-term price fluctuations for NYXH.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
NYXH vs MOBI Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, MOBI has a market cap of 356.1M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while MOBI trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas MOBI's P/E ratio is -0.57. In terms of profitability, NYXH's ROE is -1.80%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, NYXH is similarly volatile compared to MOBI. This indicates similar risk in terms of short-term price fluctuations for NYXH.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
NYXH vs ANIK Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, ANIK has a market cap of 278.9M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while ANIK trades at $20.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas ANIK's P/E ratio is 42.53. In terms of profitability, NYXH's ROE is -1.80%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, NYXH is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for NYXH.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
NYXH vs LAB Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, LAB has a market cap of 277.6M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while LAB trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas LAB's P/E ratio is -10.13. In terms of profitability, NYXH's ROE is -1.80%, compared to LAB's ROE of -0.18%. Regarding short-term risk, NYXH is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check LAB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
NYXH vs EDAP Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas EDAP's P/E ratio is -5.80. In terms of profitability, NYXH's ROE is -1.80%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, NYXH is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check EDAP's competition here
Trinity Biotech plc (NASDAQ: TRIB)
NYXH vs TRIB Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, TRIB has a market cap of 142.4M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while TRIB trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas TRIB's P/E ratio is -0.12. In terms of profitability, NYXH's ROE is -1.80%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, NYXH is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
NYXH vs APYX Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, APYX has a market cap of 126.8M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while APYX trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas APYX's P/E ratio is -15.05. In terms of profitability, NYXH's ROE is -1.80%, compared to APYX's ROE of -0.79%. Regarding short-term risk, NYXH is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
NYXH vs SKIN Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, SKIN has a market cap of 87.5M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while SKIN trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas SKIN's P/E ratio is -3.07. In terms of profitability, NYXH's ROE is -1.80%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, NYXH is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
NYXH vs DRIO Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, DRIO has a market cap of 49.6M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while DRIO trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas DRIO's P/E ratio is -1.16. In terms of profitability, NYXH's ROE is -1.80%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, NYXH is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check DRIO's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
NYXH vs MDAI Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, MDAI has a market cap of 49.3M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while MDAI trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas MDAI's P/E ratio is -3.44. In terms of profitability, NYXH's ROE is -1.80%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, NYXH is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for NYXH.Check MDAI's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
NYXH vs BEAT Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, BEAT has a market cap of 22.7M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while BEAT trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas BEAT's P/E ratio is -0.80. In terms of profitability, NYXH's ROE is -1.80%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, NYXH is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
NYXH vs BEATW Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, BEATW has a market cap of 6.3M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas BEATW's P/E ratio is -0.02. In terms of profitability, NYXH's ROE is -1.80%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, NYXH is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for NYXH.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
NYXH vs WOK Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, WOK has a market cap of 4.4M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while WOK trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas WOK's P/E ratio is N/A. In terms of profitability, NYXH's ROE is -1.80%, compared to WOK's ROE of -0.19%. Regarding short-term risk, NYXH is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
NYXH vs QTEXW Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, NYXH's ROE is -1.80%, compared to QTEXW's ROE of N/A. Regarding short-term risk, NYXH is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
NYXH vs ITOC Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, ITOC has a market cap of 2.8M. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while ITOC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas ITOC's P/E ratio is -0.96. In terms of profitability, NYXH's ROE is -1.80%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, NYXH is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
NYXH vs FEED Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas FEED's P/E ratio is -0.01. In terms of profitability, NYXH's ROE is -1.80%, compared to FEED's ROE of -0.60%. Regarding short-term risk, NYXH is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
NYXH vs TIVC Comparison September 2026
Nyxoah S.A. (NASDAQ: NYXH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NYXH stands at 155.1M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, NYXH is priced at $1.55 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NYXH currently has a P/E ratio of -0.62, whereas TIVC's P/E ratio is -0.04. In terms of profitability, NYXH's ROE is -1.80%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, NYXH is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for NYXH.Check TIVC's competition here